ArticleFrontiers in immunology2025

Cholesterol metabolism shapes immune low-response states in LUAD: a multi-omics cholesterol metabolism signature predicts immunotherapy benefit and identifies DHCR7 as a therapeutic target.

Mingjun Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.